Results 201 to 210 of about 9,372,438 (357)

Age at Onset and Rate of Alzheimer's Disease [PDF]

, 1987
Michael Borrie, Richard G. Crilly, Linda Bowring   +2 more
openalex   +1 more source

Alzheimer Disease [PDF]

Disease-a-Month, 2010
Rudy J, Castellani, Raj K, Rolston, Mark A, Smith   +2 more
openaire   +2 more sources

BrainFusion: a Low‐Code, Reproducible, and Deployable Software Framework for Multimodal Brain‒Computer Interface and Brain‒Body Interaction Research

Advanced Science, EarlyView.
BrainFusion is a low‐code software framework for multimodal brain–computer interface (BCI)​​ and brain–body interaction research. It supports ​electroencephalography (EEG)​, functional near‐infrared spectroscopy (fNIRS), electromyography (EMG)​, and electrocardiography (ECG)​​ integration with standardized preprocessing, feature fusion, and model ...
Wenhao Li, Chenyang Gao, Zhaobo Li, Yunheng Diao, Jiaxin Li, Jiayi Zhou, Jing Zhou, Ying Peng, Guanchu Chen, Xuecheng Wu, Kai Wu   +10 more
wiley   +1 more source

Aging and the Spectral Properties of Brain Hemodynamics

Advanced Science, EarlyView.
As the brain ages, its metabolic demands decline—but not uniformly. Here, spectral slope flattening of resting‐state fMRI signals is proposed as a potential biomarker of pathologic brain aging. A subset of older adults diverges from youthful spectral and metabolic patterns, with changes linked to frontal white matter pathology and regional loss of ...
Ki Yun Park, Abraham Z. Snyder, Manu S. Goyal, Timothy O. Laumann, John J. Lee, Babatunde Adeyemo, Nicholas Metcalf, Andrei G. Vlassenko, Joshua S. Shimony, Eric C. Leuthardt   +9 more
wiley   +1 more source

Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia. [PDF]

Eur J Neurol
Siguier PLM, Planton M, Pages B, Gérard F, Rafiq M, Wolfrum M, Archambault O, Damour A, Guidolin V, Pefferkorn P, Danet L, Virchien L, Magnin E, Richard-Mornas A, Sauvée M, Thomas-Antérion C, Mouton S, Jucla M, Pariente J.   +18 more
europepmc   +1 more source

ALZHEIMER'S DISEASE: THE STANDARD REFERENCE. Edited by Barry Reisberg. Published by Collier MacMillan Canada Inc., 1983. 475 pages. Illustrated. $69.95 Cdn. [PDF]

, 1986
Irma M. Parhad
openalex   +1 more source

Alzheimer’s disease [PDF]

Postgraduate Medical Journal, 1995
P, Kist, I R, Hastie
openaire   +2 more sources

MTCH2 Deficiency Promotes E2F4/TFRC‐Mediated Ferroptosis and Sensitizes Colorectal Cancer Liver Metastasis to Sorafenib

Advanced Science, EarlyView.
This study identifies MTCH2 as a crucial regulator of ferroptosis in colorectal cancer (CRC) progression. High expression of MTCH2 is correlated with poor prognosis in CRC patients. Furthermore, MTCH2 depletion induces ferroptosis to suppress CRC liver metastasis via the E2F4/TFRC axis and sensitizes tumors to sorafenib treatment, supporting MTCH2 as a
Pu Xing, Jiangbo Chen, Hao Hao, Xiaowen Qiao, Xinying Yang, Kai Weng, Jie Chen, Lin Song, Tianqi Liu, Yifan Hou, Tongkun Song, Yumeng Ran, Bo Chen, Hong Yang, Wei Zhao, Zaozao Wang, Jiabo Di, Beihai Jiang, Xiangqian Su   +18 more
wiley   +1 more source

Perinatal asphyxia and Alzheimer's disease: is there a correlation? [PDF]

Front Pediatr
Arruda BP, Martins PP, Kihara AH, Takada SH.   +3 more
europepmc   +1 more source

Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin‐Mediated Regulation of ENO1

Advanced Science, EarlyView.
Irisin is a crucial plasma biomarker and promising therapeutic target that reflects disease severity, pulmonary vascular remodeling status and clinical outcome in patients with pulmonary arterial hypertension (PAH). As a novel protective factor, irisin is downregulated in PAH. By ubiquitination, irisin promotes Enolase 1 degradation and suppresses cell
Na Sun, Yong‐Bing Wang, Jing Huang, Run‐Wei Deng, Hui‐Yu He, Lei Gao, Xuan Gao, You‐Li Fan, Yan Cong, Yao‐Lei Guo, Yi‐Qiang Chen, Gui‐Jia Wang, Shao‐Hong Fang, Xia Gu, Bo Yu, Bing‐Xiang Wu   +15 more
wiley   +1 more source